211 related articles for article (PubMed ID: 8193358)
1. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.
Kelton JG; Smith JW; Warkentin TE; Hayward CP; Denomme GA; Horsewood P
Blood; 1994 Jun; 83(11):3232-9. PubMed ID: 8193358
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
Horne MK; Hutchison KJ
Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
Newman PM; Chong BH
Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
[TBL] [Abstract][Full Text] [Related]
4. Platelet binding of IgG from patients with heparin-induced thrombocytopenia.
Horne MK; Alkins BR
J Lab Clin Med; 1996 May; 127(5):435-42. PubMed ID: 8621980
[TBL] [Abstract][Full Text] [Related]
5. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
7. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
8. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia.
Gerotziafas GT; Elalamy I; Lecrubier C; Lebrazi J; Mirshahi M; Potevin F; Lecompte T; Samama MM
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):511-20. PubMed ID: 11685038
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
10. Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia.
Weimann G; Lubenow N; Selleng K; Eichler P; Albrecht D; Greinacher A
Eur J Haematol; 2001 Mar; 66(3):195-9. PubMed ID: 11350488
[TBL] [Abstract][Full Text] [Related]
11. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP; Ford SE; Scott JP; Aster RH
J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
13. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
Lei Q; Chen L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
[TBL] [Abstract][Full Text] [Related]
14. Insights into heparin-induced thrombocytopenia.
Anderson GP
Br J Haematol; 1992 Apr; 80(4):504-8. PubMed ID: 1533786
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.
Ahmad S; Walenga JM; Jeske WP; Cella G; Fareed J
Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S32-7. PubMed ID: 10726034
[TBL] [Abstract][Full Text] [Related]
17. Micropatterned array to assess the interaction of single platelets with platelet factor 4-heparin-IgG complexes.
Medvedev N; Palankar R; Krauel K; Greinacher A; Delcea M
Thromb Haemost; 2014 May; 111(5):862-72. PubMed ID: 24452831
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia.
Chong BH; Pilgrim RL; Cooley MA; Chesterman CN
Blood; 1993 Feb; 81(4):988-93. PubMed ID: 8428005
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
Newman PM; Chong BH
Br J Haematol; 1999 Nov; 107(2):303-9. PubMed ID: 10583216
[TBL] [Abstract][Full Text] [Related]
20. Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
Pouplard C; Rollin J; Vayne C; Charuel N; Ahmadi Z; Alberio L; Azjenberg N; Althaus K; Bakchoul T; Chong B; Curtis BR; Faille D; Gomez FJ; Gresele P; Morel-Kopp MC; Mullier F; Nazy I; Smith JW; Greinacher A; Gruel Y
J Thromb Haemost; 2022 Jan; 20(1):252-259. PubMed ID: 34657390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
